BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-94@pharmaconomics
DTSTAMP:20260707T003556Z
DTSTART;VALUE=DATE:20261031
DTEND;VALUE=DATE:20261101
SUMMARY:TAK Phase 2 — TAK-788
DESCRIPTION:Phase 2 trial results for TAK-788 in Carcinoma\, Non-Small-Cell Lung are due Oct 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT02716116\n\nTrack it: https://pharmaconomics.com/e/94
URL:https://pharmaconomics.com/e/94
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TAK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR